Changzhou Qianhong Biopharma Co Ltd (002550) — Financial Flexibility Index
Changzhou Qianhong Biopharma Co Ltd (002550) has a Financial Flexibility Index of 0.67x as of September 2025. Free cash flow of CN¥171.92 Million (operating CF CN¥156.34 Million minus capex CN¥15.58 Million) represents 1% of total liabilities (CN¥255.86 Million). Check Changzhou Qianhong Biopharma Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Changzhou Qianhong Biopharma Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Changzhou Qianhong Biopharma Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see how efficiently does Changzhou Qianhong Biopharma Co Ltd generate cash.
Annual Financial Flexibility Index for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Changzhou Qianhong Biopharma Co Ltd. Explore Changzhou Qianhong Biopharma Co Ltd (002550) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥502.97 Million | CN¥361.36 Million | CN¥320.64 Million | ▼ -18.7% |
| 2024 | 1.93x | CN¥605.35 Million | CN¥514.71 Million | CN¥313.87 Million | ▼ -11.1% |
| 2023 | 2.17x | CN¥633.66 Million | CN¥533.33 Million | CN¥292.17 Million | ▲ +166574.0% |
| 2022 | 0.00x | CN¥-485.32K | CN¥-71.47 Million | CN¥372.53 Million | ▼ -100.3% |
| 2021 | 0.50x | CN¥193.94 Million | CN¥103.56 Million | CN¥390.24 Million | ▼ -49.4% |
| 2020 | 0.98x | CN¥379.81 Million | CN¥317.28 Million | CN¥386.35 Million | ▲ +125.6% |
| 2019 | 0.44x | CN¥262.23 Million | CN¥161.55 Million | CN¥601.65 Million | ▲ +116.3% |
| 2018 | 0.20x | CN¥128.98 Million | CN¥25.45 Million | CN¥640.11 Million | ▼ -32.3% |
| 2017 | 0.30x | CN¥176.15 Million | CN¥88.52 Million | CN¥591.41 Million | ▼ -49.6% |
| 2016 | 0.59x | CN¥359.95 Million | CN¥221.01 Million | CN¥609.33 Million | ▼ -36.6% |
| 2015 | 0.93x | CN¥502.28 Million | CN¥286.50 Million | CN¥538.67 Million | ▼ -51.5% |
| 2014 | 1.92x | CN¥342.54 Million | CN¥252.01 Million | CN¥178.06 Million | ▼ -36.0% |
| 2013 | 3.01x | CN¥288.06 Million | CN¥160.47 Million | CN¥95.77 Million | ▼ -33.3% |
| 2012 | 4.51x | CN¥264.02 Million | CN¥199.82 Million | CN¥58.54 Million | ▲ +126.8% |
| 2011 | 1.99x | CN¥173.13 Million | CN¥146.82 Million | CN¥87.07 Million | ▲ +47.1% |
| 2010 | 1.35x | CN¥182.15 Million | CN¥171.51 Million | CN¥134.75 Million | ▲ +1706.1% |
| 2009 | 0.07x | CN¥21.72 Million | CN¥8.35 Million | CN¥290.19 Million | ▼ -78.9% |
| 2008 | 0.36x | CN¥61.76 Million | CN¥54.36 Million | CN¥173.75 Million | ▼ -36.3% |
| 2007 | 0.56x | CN¥42.96 Million | CN¥35.99 Million | CN¥76.95 Million | — |